カテゴリ： 世界, 医療/バイオ, Market Monitor Global

アピキサバン錠のグローバル市場展望 2023年-2029年：先発医薬品、ジェネリック医薬品

■ 英語タイトル：Apixaban Tablets Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC14228）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC14228
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品
■ ページ数：121
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[アピキサバン錠のグローバル市場展望 2023年-2029年：先発医薬品、ジェネリック医薬品]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のアピキサバン錠市場規模と予測を収録しています。・世界のアピキサバン錠市場：売上、2018年-2023年、2024年-2029年
・世界のアピキサバン錠市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のアピキサバン錠市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「先発医薬品」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

アピキサバン錠のグローバル主要企業は、Bristol-Myers Squibb、 Fuan Pharmaceutical Group Ningbo Team Pharmaceutical Co., Ltd.、 Wuxi Kaifu Pharmaceutical Co., Ltd.、 YiChang HEC ChangJiang Pharmaceutical Co., Ltd.、 Chengdu Brilliant Pharmaceutical Co., Ltd.、 Jiangsu Wanbang Biopharmaceuticals、 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.、 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd.、 Chengdu Baiyu Pharmaceutical Co,.Ltd.、 Yangtze River Pharmaceutical (Group) Co., Ltd.、 Qian Jin Xiangjiang Pharmageuical、 Shanghai Pharmaceuticals Holding Co., Ltd.、 Zhejiang Hisun Pharmaceutical Co., Ltd.、 Zhejiang Huahai Pharmaceutical Co.,Ltd.、 Dr. Reddy's Laboratories、 Pinnacle Life Science、 DM Pharma、 Pfizer、 Taj Pharma、 Medichem SAなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、アピキサバン錠のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のアピキサバン錠市場：タイプ別、2018年-2023年、2024年-2029年
世界のアピキサバン錠市場：タイプ別市場シェア、2022年
・先発医薬品、ジェネリック医薬品

世界のアピキサバン錠市場：用途別、2018年-2023年、2024年-2029年
世界のアピキサバン錠市場：用途別市場シェア、2022年
・オンライン販売、オフライン小売

世界のアピキサバン錠市場：地域・国別、2018年-2023年、2024年-2029年
世界のアピキサバン錠市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるアピキサバン錠のグローバル売上、2018年-2023年
・主要企業におけるアピキサバン錠のグローバル売上シェア、2022年
・主要企業におけるアピキサバン錠のグローバル販売量、2018年-2023年
・主要企業におけるアピキサバン錠のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Bristol-Myers Squibb、 Fuan Pharmaceutical Group Ningbo Team Pharmaceutical Co., Ltd.、 Wuxi Kaifu Pharmaceutical Co., Ltd.、 YiChang HEC ChangJiang Pharmaceutical Co., Ltd.、 Chengdu Brilliant Pharmaceutical Co., Ltd.、 Jiangsu Wanbang Biopharmaceuticals、 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.、 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd.、 Chengdu Baiyu Pharmaceutical Co,.Ltd.、 Yangtze River Pharmaceutical (Group) Co., Ltd.、 Qian Jin Xiangjiang Pharmageuical、 Shanghai Pharmaceuticals Holding Co., Ltd.、 Zhejiang Hisun Pharmaceutical Co., Ltd.、 Zhejiang Huahai Pharmaceutical Co.,Ltd.、 Dr. Reddy's Laboratories、 Pinnacle Life Science、 DM Pharma、 Pfizer、 Taj Pharma、 Medichem SA

*************************************************************

・調査・分析レポートの概要
アピキサバン錠市場の定義
市場セグメント
世界のアピキサバン錠市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のアピキサバン錠市場規模
世界のアピキサバン錠市場規模：2022年 VS 2029年
世界のアピキサバン錠市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのアピキサバン錠の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のアピキサバン錠製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：先発医薬品、ジェネリック医薬品
アピキサバン錠のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：オンライン販売、オフライン小売
アピキサバン錠の用途別グローバル売上・予測

・地域別市場分析
地域別アピキサバン錠市場規模 2022年と2029年
地域別アピキサバン錠売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Bristol-Myers Squibb、 Fuan Pharmaceutical Group Ningbo Team Pharmaceutical Co., Ltd.、 Wuxi Kaifu Pharmaceutical Co., Ltd.、 YiChang HEC ChangJiang Pharmaceutical Co., Ltd.、 Chengdu Brilliant Pharmaceutical Co., Ltd.、 Jiangsu Wanbang Biopharmaceuticals、 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.、 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd.、 Chengdu Baiyu Pharmaceutical Co,.Ltd.、 Yangtze River Pharmaceutical (Group) Co., Ltd.、 Qian Jin Xiangjiang Pharmageuical、 Shanghai Pharmaceuticals Holding Co., Ltd.、 Zhejiang Hisun Pharmaceutical Co., Ltd.、 Zhejiang Huahai Pharmaceutical Co.,Ltd.、 Dr. Reddy's Laboratories、 Pinnacle Life Science、 DM Pharma、 Pfizer、 Taj Pharma、 Medichem SA
...

This research report provides a comprehensive analysis of the Apixaban Tablets market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Apixaban Tablets market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Apixaban Tablets, challenges faced by the industry, and potential opportunities for market players.
The global Apixaban Tablets market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Apixaban Tablets market presents opportunities for various stakeholders, including Online Sales, Offline Retail. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Apixaban Tablets market. Additionally, the growing consumer demand present avenues for market expansion.
The global Apixaban Tablets market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Apixaban Tablets market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Apixaban Tablets market.
Market Overview: The report provides a comprehensive overview of the Apixaban Tablets market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Original Drugs, Generic Drugs), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Apixaban Tablets market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Apixaban Tablets market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Apixaban Tablets market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Apixaban Tablets market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Apixaban Tablets market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Apixaban Tablets market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Apixaban Tablets, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Apixaban Tablets market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Apixaban Tablets market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Original Drugs
Generic Drugs
Market segment by Application
Online Sales
Offline Retail
Global Apixaban Tablets Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Bristol-Myers Squibb
Fuan Pharmaceutical Group Ningbo Team Pharmaceutical Co., Ltd.
Wuxi Kaifu Pharmaceutical Co., Ltd.
YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
Chengdu Brilliant Pharmaceutical Co., Ltd.
Jiangsu Wanbang Biopharmaceuticals
Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.
Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd.
Chengdu Baiyu Pharmaceutical Co,.Ltd.
Yangtze River Pharmaceutical (Group) Co., Ltd.
Qian Jin Xiangjiang Pharmageuical
Shanghai Pharmaceuticals Holding Co., Ltd.
Zhejiang Hisun Pharmaceutical Co., Ltd.
Zhejiang Huahai Pharmaceutical Co.,Ltd.
Dr. Reddy’s Laboratories
Pinnacle Life Science
DM Pharma
Pfizer
Taj Pharma
Medichem SA
Outline of Major Chapters:
Chapter 1: Introduces the definition of Apixaban Tablets, market overview.
Chapter 2: Global Apixaban Tablets market size in revenue and volume.
Chapter 3: Detailed analysis of Apixaban Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Apixaban Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Apixaban Tablets capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Apixaban Tablets Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Apixaban Tablets Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Apixaban Tablets Overall Market Size
2.1 Global Apixaban Tablets Market Size: 2022 VS 2029
2.2 Global Apixaban Tablets Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Apixaban Tablets Sales: 2018-2029
3 Company Landscape
3.1 Top Apixaban Tablets Players in Global Market
3.2 Top Global Apixaban Tablets Companies Ranked by Revenue
3.3 Global Apixaban Tablets Revenue by Companies
3.4 Global Apixaban Tablets Sales by Companies
3.5 Global Apixaban Tablets Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Apixaban Tablets Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Apixaban Tablets Product Type
3.8 Tier 1, Tier 2 and Tier 3 Apixaban Tablets Players in Global Market
3.8.1 List of Global Tier 1 Apixaban Tablets Companies
3.8.2 List of Global Tier 2 and Tier 3 Apixaban Tablets Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Apixaban Tablets Market Size Markets, 2022 & 2029
4.1.2 Original Drugs
4.1.3 Generic Drugs
4.2 By Type – Global Apixaban Tablets Revenue & Forecasts
4.2.1 By Type – Global Apixaban Tablets Revenue, 2018-2023
4.2.2 By Type – Global Apixaban Tablets Revenue, 2024-2029
4.2.3 By Type – Global Apixaban Tablets Revenue Market Share, 2018-2029
4.3 By Type – Global Apixaban Tablets Sales & Forecasts
4.3.1 By Type – Global Apixaban Tablets Sales, 2018-2023
4.3.2 By Type – Global Apixaban Tablets Sales, 2024-2029
4.3.3 By Type – Global Apixaban Tablets Sales Market Share, 2018-2029
4.4 By Type – Global Apixaban Tablets Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Apixaban Tablets Market Size, 2022 & 2029
5.1.2 Online Sales
5.1.3 Offline Retail
5.2 By Application – Global Apixaban Tablets Revenue & Forecasts
5.2.1 By Application – Global Apixaban Tablets Revenue, 2018-2023
5.2.2 By Application – Global Apixaban Tablets Revenue, 2024-2029
5.2.3 By Application – Global Apixaban Tablets Revenue Market Share, 2018-2029
5.3 By Application – Global Apixaban Tablets Sales & Forecasts
5.3.1 By Application – Global Apixaban Tablets Sales, 2018-2023
5.3.2 By Application – Global Apixaban Tablets Sales, 2024-2029
5.3.3 By Application – Global Apixaban Tablets Sales Market Share, 2018-2029
5.4 By Application – Global Apixaban Tablets Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Apixaban Tablets Market Size, 2022 & 2029
6.2 By Region – Global Apixaban Tablets Revenue & Forecasts
6.2.1 By Region – Global Apixaban Tablets Revenue, 2018-2023
6.2.2 By Region – Global Apixaban Tablets Revenue, 2024-2029
6.2.3 By Region – Global Apixaban Tablets Revenue Market Share, 2018-2029
6.3 By Region – Global Apixaban Tablets Sales & Forecasts
6.3.1 By Region – Global Apixaban Tablets Sales, 2018-2023
6.3.2 By Region – Global Apixaban Tablets Sales, 2024-2029
6.3.3 By Region – Global Apixaban Tablets Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Apixaban Tablets Revenue, 2018-2029
6.4.2 By Country – North America Apixaban Tablets Sales, 2018-2029
6.4.3 US Apixaban Tablets Market Size, 2018-2029
6.4.4 Canada Apixaban Tablets Market Size, 2018-2029
6.4.5 Mexico Apixaban Tablets Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Apixaban Tablets Revenue, 2018-2029
6.5.2 By Country – Europe Apixaban Tablets Sales, 2018-2029
6.5.3 Germany Apixaban Tablets Market Size, 2018-2029
6.5.4 France Apixaban Tablets Market Size, 2018-2029
6.5.5 U.K. Apixaban Tablets Market Size, 2018-2029
6.5.6 Italy Apixaban Tablets Market Size, 2018-2029
6.5.7 Russia Apixaban Tablets Market Size, 2018-2029
6.5.8 Nordic Countries Apixaban Tablets Market Size, 2018-2029
6.5.9 Benelux Apixaban Tablets Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Apixaban Tablets Revenue, 2018-2029
6.6.2 By Region – Asia Apixaban Tablets Sales, 2018-2029
6.6.3 China Apixaban Tablets Market Size, 2018-2029
6.6.4 Japan Apixaban Tablets Market Size, 2018-2029
6.6.5 South Korea Apixaban Tablets Market Size, 2018-2029
6.6.6 Southeast Asia Apixaban Tablets Market Size, 2018-2029
6.6.7 India Apixaban Tablets Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Apixaban Tablets Revenue, 2018-2029
6.7.2 By Country – South America Apixaban Tablets Sales, 2018-2029
6.7.3 Brazil Apixaban Tablets Market Size, 2018-2029
6.7.4 Argentina Apixaban Tablets Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Apixaban Tablets Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Apixaban Tablets Sales, 2018-2029
6.8.3 Turkey Apixaban Tablets Market Size, 2018-2029
6.8.4 Israel Apixaban Tablets Market Size, 2018-2029
6.8.5 Saudi Arabia Apixaban Tablets Market Size, 2018-2029
6.8.6 UAE Apixaban Tablets Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Bristol-Myers Squibb
7.1.1 Bristol-Myers Squibb Company Summary
7.1.2 Bristol-Myers Squibb Business Overview
7.1.3 Bristol-Myers Squibb Apixaban Tablets Major Product Offerings
7.1.4 Bristol-Myers Squibb Apixaban Tablets Sales and Revenue in Global (2018-2023)
7.1.5 Bristol-Myers Squibb Key News & Latest Developments
7.2 Fuan Pharmaceutical Group Ningbo Team Pharmaceutical Co., Ltd.
7.2.1 Fuan Pharmaceutical Group Ningbo Team Pharmaceutical Co., Ltd. Company Summary
7.2.2 Fuan Pharmaceutical Group Ningbo Team Pharmaceutical Co., Ltd. Business Overview
7.2.3 Fuan Pharmaceutical Group Ningbo Team Pharmaceutical Co., Ltd. Apixaban Tablets Major Product Offerings
7.2.4 Fuan Pharmaceutical Group Ningbo Team Pharmaceutical Co., Ltd. Apixaban Tablets Sales and Revenue in Global (2018-2023)
7.2.5 Fuan Pharmaceutical Group Ningbo Team Pharmaceutical Co., Ltd. Key News & Latest Developments
7.3 Wuxi Kaifu Pharmaceutical Co., Ltd.
7.3.1 Wuxi Kaifu Pharmaceutical Co., Ltd. Company Summary
7.3.2 Wuxi Kaifu Pharmaceutical Co., Ltd. Business Overview
7.3.3 Wuxi Kaifu Pharmaceutical Co., Ltd. Apixaban Tablets Major Product Offerings
7.3.4 Wuxi Kaifu Pharmaceutical Co., Ltd. Apixaban Tablets Sales and Revenue in Global (2018-2023)
7.3.5 Wuxi Kaifu Pharmaceutical Co., Ltd. Key News & Latest Developments
7.4 YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
7.4.1 YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Company Summary
7.4.2 YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Business Overview
7.4.3 YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Apixaban Tablets Major Product Offerings
7.4.4 YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Apixaban Tablets Sales and Revenue in Global (2018-2023)
7.4.5 YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Key News & Latest Developments
7.5 Chengdu Brilliant Pharmaceutical Co., Ltd.
7.5.1 Chengdu Brilliant Pharmaceutical Co., Ltd. Company Summary
7.5.2 Chengdu Brilliant Pharmaceutical Co., Ltd. Business Overview
7.5.3 Chengdu Brilliant Pharmaceutical Co., Ltd. Apixaban Tablets Major Product Offerings
7.5.4 Chengdu Brilliant Pharmaceutical Co., Ltd. Apixaban Tablets Sales and Revenue in Global (2018-2023)
7.5.5 Chengdu Brilliant Pharmaceutical Co., Ltd. Key News & Latest Developments
7.6 Jiangsu Wanbang Biopharmaceuticals
7.6.1 Jiangsu Wanbang Biopharmaceuticals Company Summary
7.6.2 Jiangsu Wanbang Biopharmaceuticals Business Overview
7.6.3 Jiangsu Wanbang Biopharmaceuticals Apixaban Tablets Major Product Offerings
7.6.4 Jiangsu Wanbang Biopharmaceuticals Apixaban Tablets Sales and Revenue in Global (2018-2023)
7.6.5 Jiangsu Wanbang Biopharmaceuticals Key News & Latest Developments
7.7 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.
7.7.1 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Company Summary
7.7.2 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Business Overview
7.7.3 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Apixaban Tablets Major Product Offerings
7.7.4 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Apixaban Tablets Sales and Revenue in Global (2018-2023)
7.7.5 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Key News & Latest Developments
7.8 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd.
7.8.1 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Company Summary
7.8.2 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Business Overview
7.8.3 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Apixaban Tablets Major Product Offerings
7.8.4 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Apixaban Tablets Sales and Revenue in Global (2018-2023)
7.8.5 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Key News & Latest Developments
7.9 Chengdu Baiyu Pharmaceutical Co,.Ltd.
7.9.1 Chengdu Baiyu Pharmaceutical Co,.Ltd. Company Summary
7.9.2 Chengdu Baiyu Pharmaceutical Co,.Ltd. Business Overview
7.9.3 Chengdu Baiyu Pharmaceutical Co,.Ltd. Apixaban Tablets Major Product Offerings
7.9.4 Chengdu Baiyu Pharmaceutical Co,.Ltd. Apixaban Tablets Sales and Revenue in Global (2018-2023)
7.9.5 Chengdu Baiyu Pharmaceutical Co,.Ltd. Key News & Latest Developments
7.10 Yangtze River Pharmaceutical (Group) Co., Ltd.
7.10.1 Yangtze River Pharmaceutical (Group) Co., Ltd. Company Summary
7.10.2 Yangtze River Pharmaceutical (Group) Co., Ltd. Business Overview
7.10.3 Yangtze River Pharmaceutical (Group) Co., Ltd. Apixaban Tablets Major Product Offerings
7.10.4 Yangtze River Pharmaceutical (Group) Co., Ltd. Apixaban Tablets Sales and Revenue in Global (2018-2023)
7.10.5 Yangtze River Pharmaceutical (Group) Co., Ltd. Key News & Latest Developments
7.11 Qian Jin Xiangjiang Pharmageuical
7.11.1 Qian Jin Xiangjiang Pharmageuical Company Summary
7.11.2 Qian Jin Xiangjiang Pharmageuical Business Overview
7.11.3 Qian Jin Xiangjiang Pharmageuical Apixaban Tablets Major Product Offerings
7.11.4 Qian Jin Xiangjiang Pharmageuical Apixaban Tablets Sales and Revenue in Global (2018-2023)
7.11.5 Qian Jin Xiangjiang Pharmageuical Key News & Latest Developments
7.12 Shanghai Pharmaceuticals Holding Co., Ltd.
7.12.1 Shanghai Pharmaceuticals Holding Co., Ltd. Company Summary
7.12.2 Shanghai Pharmaceuticals Holding Co., Ltd. Business Overview
7.12.3 Shanghai Pharmaceuticals Holding Co., Ltd. Apixaban Tablets Major Product Offerings
7.12.4 Shanghai Pharmaceuticals Holding Co., Ltd. Apixaban Tablets Sales and Revenue in Global (2018-2023)
7.12.5 Shanghai Pharmaceuticals Holding Co., Ltd. Key News & Latest Developments
7.13 Zhejiang Hisun Pharmaceutical Co., Ltd.
7.13.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Company Summary
7.13.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Business Overview
7.13.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Apixaban Tablets Major Product Offerings
7.13.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Apixaban Tablets Sales and Revenue in Global (2018-2023)
7.13.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Key News & Latest Developments
7.14 Zhejiang Huahai Pharmaceutical Co.,Ltd.
7.14.1 Zhejiang Huahai Pharmaceutical Co.,Ltd. Company Summary
7.14.2 Zhejiang Huahai Pharmaceutical Co.,Ltd. Business Overview
7.14.3 Zhejiang Huahai Pharmaceutical Co.,Ltd. Apixaban Tablets Major Product Offerings
7.14.4 Zhejiang Huahai Pharmaceutical Co.,Ltd. Apixaban Tablets Sales and Revenue in Global (2018-2023)
7.14.5 Zhejiang Huahai Pharmaceutical Co.,Ltd. Key News & Latest Developments
7.15 Dr. Reddy’s Laboratories
7.15.1 Dr. Reddy’s Laboratories Company Summary
7.15.2 Dr. Reddy’s Laboratories Business Overview
7.15.3 Dr. Reddy’s Laboratories Apixaban Tablets Major Product Offerings
7.15.4 Dr. Reddy’s Laboratories Apixaban Tablets Sales and Revenue in Global (2018-2023)
7.15.5 Dr. Reddy’s Laboratories Key News & Latest Developments
7.16 Pinnacle Life Science
7.16.1 Pinnacle Life Science Company Summary
7.16.2 Pinnacle Life Science Business Overview
7.16.3 Pinnacle Life Science Apixaban Tablets Major Product Offerings
7.16.4 Pinnacle Life Science Apixaban Tablets Sales and Revenue in Global (2018-2023)
7.16.5 Pinnacle Life Science Key News & Latest Developments
7.17 DM Pharma
7.17.1 DM Pharma Company Summary
7.17.2 DM Pharma Business Overview
7.17.3 DM Pharma Apixaban Tablets Major Product Offerings
7.17.4 DM Pharma Apixaban Tablets Sales and Revenue in Global (2018-2023)
7.17.5 DM Pharma Key News & Latest Developments
7.18 Pfizer
7.18.1 Pfizer Company Summary
7.18.2 Pfizer Business Overview
7.18.3 Pfizer Apixaban Tablets Major Product Offerings
7.18.4 Pfizer Apixaban Tablets Sales and Revenue in Global (2018-2023)
7.18.5 Pfizer Key News & Latest Developments
7.19 Taj Pharma
7.19.1 Taj Pharma Company Summary
7.19.2 Taj Pharma Business Overview
7.19.3 Taj Pharma Apixaban Tablets Major Product Offerings
7.19.4 Taj Pharma Apixaban Tablets Sales and Revenue in Global (2018-2023)
7.19.5 Taj Pharma Key News & Latest Developments
7.20 Medichem SA
7.20.1 Medichem SA Company Summary
7.20.2 Medichem SA Business Overview
7.20.3 Medichem SA Apixaban Tablets Major Product Offerings
7.20.4 Medichem SA Apixaban Tablets Sales and Revenue in Global (2018-2023)
7.20.5 Medichem SA Key News & Latest Developments
8 Global Apixaban Tablets Production Capacity, Analysis
8.1 Global Apixaban Tablets Production Capacity, 2018-2029
8.2 Apixaban Tablets Production Capacity of Key Manufacturers in Global Market
8.3 Global Apixaban Tablets Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Apixaban Tablets Supply Chain Analysis
10.1 Apixaban Tablets Industry Value Chain
10.2 Apixaban Tablets Upstream Market
10.3 Apixaban Tablets Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Apixaban Tablets Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Apixaban Tablets in Global Market
Table 2. Top Apixaban Tablets Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Apixaban Tablets Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Apixaban Tablets Revenue Share by Companies, 2018-2023
Table 5. Global Apixaban Tablets Sales by Companies, (K Boxes), 2018-2023
Table 6. Global Apixaban Tablets Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Apixaban Tablets Price (2018-2023) & (US$/Box)
Table 8. Global Manufacturers Apixaban Tablets Product Type
Table 9. List of Global Tier 1 Apixaban Tablets Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Apixaban Tablets Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Apixaban Tablets Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Apixaban Tablets Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Apixaban Tablets Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Apixaban Tablets Sales (K Boxes), 2018-2023
Table 15. By Type - Global Apixaban Tablets Sales (K Boxes), 2024-2029
Table 16. By Application – Global Apixaban Tablets Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Apixaban Tablets Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Apixaban Tablets Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Apixaban Tablets Sales (K Boxes), 2018-2023
Table 20. By Application - Global Apixaban Tablets Sales (K Boxes), 2024-2029
Table 21. By Region – Global Apixaban Tablets Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Apixaban Tablets Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Apixaban Tablets Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Apixaban Tablets Sales (K Boxes), 2018-2023
Table 25. By Region - Global Apixaban Tablets Sales (K Boxes), 2024-2029
Table 26. By Country - North America Apixaban Tablets Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Apixaban Tablets Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Apixaban Tablets Sales, (K Boxes), 2018-2023
Table 29. By Country - North America Apixaban Tablets Sales, (K Boxes), 2024-2029
Table 30. By Country - Europe Apixaban Tablets Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Apixaban Tablets Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Apixaban Tablets Sales, (K Boxes), 2018-2023
Table 33. By Country - Europe Apixaban Tablets Sales, (K Boxes), 2024-2029
Table 34. By Region - Asia Apixaban Tablets Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Apixaban Tablets Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Apixaban Tablets Sales, (K Boxes), 2018-2023
Table 37. By Region - Asia Apixaban Tablets Sales, (K Boxes), 2024-2029
Table 38. By Country - South America Apixaban Tablets Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Apixaban Tablets Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Apixaban Tablets Sales, (K Boxes), 2018-2023
Table 41. By Country - South America Apixaban Tablets Sales, (K Boxes), 2024-2029
Table 42. By Country - Middle East & Africa Apixaban Tablets Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Apixaban Tablets Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Apixaban Tablets Sales, (K Boxes), 2018-2023
Table 45. By Country - Middle East & Africa Apixaban Tablets Sales, (K Boxes), 2024-2029
Table 46. Bristol-Myers Squibb Company Summary
Table 47. Bristol-Myers Squibb Apixaban Tablets Product Offerings
Table 48. Bristol-Myers Squibb Apixaban Tablets Sales (K Boxes), Revenue (US$, Mn) and Average Price (US$/Box) (2018-2023)
Table 49. Bristol-Myers Squibb Key News & Latest Developments
Table 50. Fuan Pharmaceutical Group Ningbo Team Pharmaceutical Co., Ltd. Company Summary
Table 51. Fuan Pharmaceutical Group Ningbo Team Pharmaceutical Co., Ltd. Apixaban Tablets Product Offerings
Table 52. Fuan Pharmaceutical Group Ningbo Team Pharmaceutical Co., Ltd. Apixaban Tablets Sales (K Boxes), Revenue (US$, Mn) and Average Price (US$/Box) (2018-2023)
Table 53. Fuan Pharmaceutical Group Ningbo Team Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 54. Wuxi Kaifu Pharmaceutical Co., Ltd. Company Summary
Table 55. Wuxi Kaifu Pharmaceutical Co., Ltd. Apixaban Tablets Product Offerings
Table 56. Wuxi Kaifu Pharmaceutical Co., Ltd. Apixaban Tablets Sales (K Boxes), Revenue (US$, Mn) and Average Price (US$/Box) (2018-2023)
Table 57. Wuxi Kaifu Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 58. YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Company Summary
Table 59. YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Apixaban Tablets Product Offerings
Table 60. YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Apixaban Tablets Sales (K Boxes), Revenue (US$, Mn) and Average Price (US$/Box) (2018-2023)
Table 61. YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 62. Chengdu Brilliant Pharmaceutical Co., Ltd. Company Summary
Table 63. Chengdu Brilliant Pharmaceutical Co., Ltd. Apixaban Tablets Product Offerings
Table 64. Chengdu Brilliant Pharmaceutical Co., Ltd. Apixaban Tablets Sales (K Boxes), Revenue (US$, Mn) and Average Price (US$/Box) (2018-2023)
Table 65. Chengdu Brilliant Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 66. Jiangsu Wanbang Biopharmaceuticals Company Summary
Table 67. Jiangsu Wanbang Biopharmaceuticals Apixaban Tablets Product Offerings
Table 68. Jiangsu Wanbang Biopharmaceuticals Apixaban Tablets Sales (K Boxes), Revenue (US$, Mn) and Average Price (US$/Box) (2018-2023)
Table 69. Jiangsu Wanbang Biopharmaceuticals Key News & Latest Developments
Table 70. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Company Summary
Table 71. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Apixaban Tablets Product Offerings
Table 72. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Apixaban Tablets Sales (K Boxes), Revenue (US$, Mn) and Average Price (US$/Box) (2018-2023)
Table 73. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 74. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Company Summary
Table 75. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Apixaban Tablets Product Offerings
Table 76. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Apixaban Tablets Sales (K Boxes), Revenue (US$, Mn) and Average Price (US$/Box) (2018-2023)
Table 77. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Key News & Latest Developments
Table 78. Chengdu Baiyu Pharmaceutical Co,.Ltd. Company Summary
Table 79. Chengdu Baiyu Pharmaceutical Co,.Ltd. Apixaban Tablets Product Offerings
Table 80. Chengdu Baiyu Pharmaceutical Co,.Ltd. Apixaban Tablets Sales (K Boxes), Revenue (US$, Mn) and Average Price (US$/Box) (2018-2023)
Table 81. Chengdu Baiyu Pharmaceutical Co,.Ltd. Key News & Latest Developments
Table 82. Yangtze River Pharmaceutical (Group) Co., Ltd. Company Summary
Table 83. Yangtze River Pharmaceutical (Group) Co., Ltd. Apixaban Tablets Product Offerings
Table 84. Yangtze River Pharmaceutical (Group) Co., Ltd. Apixaban Tablets Sales (K Boxes), Revenue (US$, Mn) and Average Price (US$/Box) (2018-2023)
Table 85. Yangtze River Pharmaceutical (Group) Co., Ltd. Key News & Latest Developments
Table 86. Qian Jin Xiangjiang Pharmageuical Company Summary
Table 87. Qian Jin Xiangjiang Pharmageuical Apixaban Tablets Product Offerings
Table 88. Qian Jin Xiangjiang Pharmageuical Apixaban Tablets Sales (K Boxes), Revenue (US$, Mn) and Average Price (US$/Box) (2018-2023)
Table 89. Qian Jin Xiangjiang Pharmageuical Key News & Latest Developments
Table 90. Shanghai Pharmaceuticals Holding Co., Ltd. Company Summary
Table 91. Shanghai Pharmaceuticals Holding Co., Ltd. Apixaban Tablets Product Offerings
Table 92. Shanghai Pharmaceuticals Holding Co., Ltd. Apixaban Tablets Sales (K Boxes), Revenue (US$, Mn) and Average Price (US$/Box) (2018-2023)
Table 93. Shanghai Pharmaceuticals Holding Co., Ltd. Key News & Latest Developments
Table 94. Zhejiang Hisun Pharmaceutical Co., Ltd. Company Summary
Table 95. Zhejiang Hisun Pharmaceutical Co., Ltd. Apixaban Tablets Product Offerings
Table 96. Zhejiang Hisun Pharmaceutical Co., Ltd. Apixaban Tablets Sales (K Boxes), Revenue (US$, Mn) and Average Price (US$/Box) (2018-2023)
Table 97. Zhejiang Hisun Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 98. Zhejiang Huahai Pharmaceutical Co.,Ltd. Company Summary
Table 99. Zhejiang Huahai Pharmaceutical Co.,Ltd. Apixaban Tablets Product Offerings
Table 100. Zhejiang Huahai Pharmaceutical Co.,Ltd. Apixaban Tablets Sales (K Boxes), Revenue (US$, Mn) and Average Price (US$/Box) (2018-2023)
Table 101. Zhejiang Huahai Pharmaceutical Co.,Ltd. Key News & Latest Developments
Table 102. Dr. Reddy's Laboratories Company Summary
Table 103. Dr. Reddy's Laboratories Apixaban Tablets Product Offerings
Table 104. Dr. Reddy's Laboratories Apixaban Tablets Sales (K Boxes), Revenue (US$, Mn) and Average Price (US$/Box) (2018-2023)
Table 105. Dr. Reddy's Laboratories Key News & Latest Developments
Table 106. Pinnacle Life Science Company Summary
Table 107. Pinnacle Life Science Apixaban Tablets Product Offerings
Table 108. Pinnacle Life Science Apixaban Tablets Sales (K Boxes), Revenue (US$, Mn) and Average Price (US$/Box) (2018-2023)
Table 109. Pinnacle Life Science Key News & Latest Developments
Table 110. DM Pharma Company Summary
Table 111. DM Pharma Apixaban Tablets Product Offerings
Table 112. DM Pharma Apixaban Tablets Sales (K Boxes), Revenue (US$, Mn) and Average Price (US$/Box) (2018-2023)
Table 113. DM Pharma Key News & Latest Developments
Table 114. Pfizer Company Summary
Table 115. Pfizer Apixaban Tablets Product Offerings
Table 116. Pfizer Apixaban Tablets Sales (K Boxes), Revenue (US$, Mn) and Average Price (US$/Box) (2018-2023)
Table 117. Pfizer Key News & Latest Developments
Table 118. Taj Pharma Company Summary
Table 119. Taj Pharma Apixaban Tablets Product Offerings
Table 120. Taj Pharma Apixaban Tablets Sales (K Boxes), Revenue (US$, Mn) and Average Price (US$/Box) (2018-2023)
Table 121. Taj Pharma Key News & Latest Developments
Table 122. Medichem SA Company Summary
Table 123. Medichem SA Apixaban Tablets Product Offerings
Table 124. Medichem SA Apixaban Tablets Sales (K Boxes), Revenue (US$, Mn) and Average Price (US$/Box) (2018-2023)
Table 125. Medichem SA Key News & Latest Developments
Table 126. Apixaban Tablets Production Capacity (K Boxes) of Key Manufacturers in Global Market, 2021-2023 (K Boxes)
Table 127. Global Apixaban Tablets Capacity Market Share of Key Manufacturers, 2021-2023
Table 128. Global Apixaban Tablets Production by Region, 2018-2023 (K Boxes)
Table 129. Global Apixaban Tablets Production by Region, 2024-2029 (K Boxes)
Table 130. Apixaban Tablets Market Opportunities & Trends in Global Market
Table 131. Apixaban Tablets Market Drivers in Global Market
Table 132. Apixaban Tablets Market Restraints in Global Market
Table 133. Apixaban Tablets Raw Materials
Table 134. Apixaban Tablets Raw Materials Suppliers in Global Market
Table 135. Typical Apixaban Tablets Downstream
Table 136. Apixaban Tablets Downstream Clients in Global Market
Table 137. Apixaban Tablets Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Apixaban Tablets Segment by Type in 2022
Figure 2. Apixaban Tablets Segment by Application in 2022
Figure 3. Global Apixaban Tablets Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Apixaban Tablets Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Apixaban Tablets Revenue, 2018-2029 (US$, Mn)
Figure 7. Apixaban Tablets Sales in Global Market: 2018-2029 (K Boxes)
Figure 8. The Top 3 and 5 Players Market Share by Apixaban Tablets Revenue in 2022
Figure 9. By Type - Global Apixaban Tablets Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Apixaban Tablets Revenue Market Share, 2018-2029
Figure 11. By Type - Global Apixaban Tablets Sales Market Share, 2018-2029
Figure 12. By Type - Global Apixaban Tablets Price (US$/Box), 2018-2029
Figure 13. By Application - Global Apixaban Tablets Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Apixaban Tablets Revenue Market Share, 2018-2029
Figure 15. By Application - Global Apixaban Tablets Sales Market Share, 2018-2029
Figure 16. By Application - Global Apixaban Tablets Price (US$/Box), 2018-2029
Figure 17. By Region - Global Apixaban Tablets Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Apixaban Tablets Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Apixaban Tablets Revenue Market Share, 2018-2029
Figure 20. By Region - Global Apixaban Tablets Sales Market Share, 2018-2029
Figure 21. By Country - North America Apixaban Tablets Revenue Market Share, 2018-2029
Figure 22. By Country - North America Apixaban Tablets Sales Market Share, 2018-2029
Figure 23. US Apixaban Tablets Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Apixaban Tablets Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Apixaban Tablets Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Apixaban Tablets Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Apixaban Tablets Sales Market Share, 2018-2029
Figure 28. Germany Apixaban Tablets Revenue, (US$, Mn), 2018-2029
Figure 29. France Apixaban Tablets Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Apixaban Tablets Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Apixaban Tablets Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Apixaban Tablets Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Apixaban Tablets Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Apixaban Tablets Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Apixaban Tablets Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Apixaban Tablets Sales Market Share, 2018-2029
Figure 37. China Apixaban Tablets Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Apixaban Tablets Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Apixaban Tablets Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Apixaban Tablets Revenue, (US$, Mn), 2018-2029
Figure 41. India Apixaban Tablets Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Apixaban Tablets Revenue Market Share, 2018-2029
Figure 43. By Country - South America Apixaban Tablets Sales Market Share, 2018-2029
Figure 44. Brazil Apixaban Tablets Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Apixaban Tablets Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Apixaban Tablets Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Apixaban Tablets Sales Market Share, 2018-2029
Figure 48. Turkey Apixaban Tablets Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Apixaban Tablets Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Apixaban Tablets Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Apixaban Tablets Revenue, (US$, Mn), 2018-2029
Figure 52. Global Apixaban Tablets Production Capacity (K Boxes), 2018-2029
Figure 53. The Percentage of Production Apixaban Tablets by Region, 2022 VS 2029
Figure 54. Apixaban Tablets Industry Value Chain
Figure 55. Marketing Channels


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • リン酸テディゾリド錠のグローバル市場展望 2023年-2029年：先発医薬品、ジェネリック医薬品
  • テノフォビルアラフェナミドフマル酸塩錠剤のグローバル市場展望 2023年-2029年：先発医薬品、ジェネリック医薬品
  • イソニアジド注射液のグローバル市場展望 2023年-2029年：ジェネリック医薬品、先発医薬品
  • ニンテダニブエシレートソフトカプセルのグローバル市場展望 2023年-2029年：先発医薬品、ジェネリック医薬品
  • 注射用アザシチジンの世界市場2023年：先発医薬品、ジェネリック医薬品
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC14228 )"アピキサバン錠のグローバル市場展望 2023年-2029年：先発医薬品、ジェネリック医薬品" (英文：Apixaban Tablets Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。